Literature DB >> 2875178

A physiological basis for subclassifying beta-adrenoceptors examined by chemical sympathectomy of guinea-pigs.

K J Broadley, R G Chess-Williams, P F Grassby.   

Abstract

Chemical sympathectomy of guinea-pigs was induced by chronic pretreatment with 6-hydroxydopamine over a 20 day period. Control animals were sham injected with vehicle at the same times. Isolated tissues were removed from the animals and beta-adrenoceptor sensitivity assessed from cumulative concentration-response curves for isoprenaline, followed after wash-out by a partial agonist (salbutamol, ritodrine or prenalterol). The following responses were measured: increases in force and rate of contraction of left and right atria respectively, inhibition of carbachol-induced ileal contractions, relaxation of intrinsic tone of lung strips and tracheal spirals, inhibition of contractions of vas deferens and soleus muscle induced by field stimulation. Left and right atria and ileum from 6-hydroxydopamine-pretreated guinea-pigs exhibited supersensitivity to beta-adrenoceptor stimulation. This was measured as a leftwards shift of the concentration-response curve for isoprenaline and as an elevation of the partial agonist maximum response (relative to isoprenaline), when compared with tissues from sham-injected controls. The supersensitivity was assumed to be due to the loss of endogenous neurotransmitter release by chemical sympathectomy and specific for the beta-adrenoceptor. In contrast, lung strips, vas deferens and soleus muscle were not supersensitive. The responses of these tissues are thought to be mediated via beta 2-adrenoceptors whereas cardiac and ileal responses are beta 1-adrenoceptor mediated. The latter receptor subtype would therefore appear to be under the influence of sympathetic innervation, but since no supersensitivity occurred at beta 2-adrenoceptors these were presumed to be non-innervated but stimulated by circulating adrenaline. These results obtained by use of chemical sympathectomy with 6-hydroxydopamine support the contention that the physiological basis of beta-adrenoceptor subclassification is that the beta 1-subtype are innervated whereas the beta 2-subtype are non-innervated.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2875178      PMCID: PMC1182543          DOI: 10.1113/jphysiol.1986.sp016053

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  29 in total

1.  THE SPIRALLY CUT TRACHEAL STRIP PREPARATION.

Authors:  J W CONSTANTINE
Journal:  J Pharm Pharmacol       Date:  1965-06       Impact factor: 3.765

2.  ADRENERGIC INNERVATION OF THE INTESTINAL WALL STUDIED BY FLUORESCENCE MICROSCOPY.

Authors:  K A NORBERG
Journal:  Int J Neuropharmacol       Date:  1964-09

Review 3.  Actions of sympathomimetic amines and their antagonists on skeletal muscle.

Authors:  W C Bowman; M W Nott
Journal:  Pharmacol Rev       Date:  1969-03       Impact factor: 25.468

4.  The supersensitivity of isolated rabbit atria and aortic strips produced by 6-hydroxydopamine.

Authors:  S Shibata; M Kuchii; K Kurahashi
Journal:  Eur J Pharmacol       Date:  1972-05       Impact factor: 4.432

5.  Regional distribution of catecholamines in the hearts of various species.

Authors:  E T Angelakos; M P King; R W Millard
Journal:  Ann N Y Acad Sci       Date:  1969-01-31       Impact factor: 5.691

6.  An homogeneous population of beta 1-adrenoceptors subserves inhibitory responses in guinea-pig ileal preparations.

Authors:  M A Mian; E Malta; C Raper
Journal:  J Pharm Pharmacol       Date:  1984-10       Impact factor: 3.765

7.  Supersensitivity of the isolated rat heart after chemical sympathectomy with 6-hydroxydopamine.

Authors:  R A Nadeau; J de Champlain; G M Tremblay
Journal:  Can J Physiol Pharmacol       Date:  1971-01       Impact factor: 2.273

8.  Differentiation of receptor systems activated by sympathomimetic amines.

Authors:  A M Lands; A Arnold; J P McAuliff; F P Luduena; T G Brown
Journal:  Nature       Date:  1967-05-06       Impact factor: 49.962

9.  Actions of some sympathomimetic bronchodilator and beta-adrenoceptor blocking drugs on contractions of the cat soleus muscle.

Authors:  W C Bowman; M W Nott
Journal:  Br J Pharmacol       Date:  1970-01       Impact factor: 8.739

10.  Reserpine-induced supersensitivity occurs for beta-adrenoceptor-mediated responses of heart and trachea but not of the uterus and lung.

Authors:  M H Hawthorn; K J Broadley
Journal:  Eur J Pharmacol       Date:  1984-10-15       Impact factor: 4.432

View more
  6 in total

1.  Perturbation of upper gastrointestinal transit and antroduodenal motility by experimentally applied stress: the role of beta-adrenoreceptor mediated pathways.

Authors:  J D O'Brien; D G Thompson; S J Day; W R Burnham; E Walker
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

2.  Chronic (-)-isoprenaline infusion down-regulates beta 1- and beta 2-adrenoceptors but does not transregulate muscarinic cholinoceptors in rat heart.

Authors:  J M Matthews; P H Falckh; P Molenaar; R J Summers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-01       Impact factor: 3.000

3.  Evidence that an atypical beta-adrenoceptor mediates the inhibition of spontaneous rhythmical contractions of rabbit isolated jejunum induced by ritodrine and salbutamol.

Authors:  B J Norman; H L Leathard
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

4.  Genetic regulation of beta 2-adrenergic receptors in 3T3-L1 fibroblasts.

Authors:  M T Nakada; K M Haskell; D J Ecker; J M Stadel; S T Crooke
Journal:  Biochem J       Date:  1989-05-15       Impact factor: 3.857

5.  Reflex regulation of airway sympathetic nerves in guinea-pigs.

Authors:  Eun Joo Oh; Stuart B Mazzone; Brendan J Canning; Daniel Weinreich
Journal:  J Physiol       Date:  2006-03-31       Impact factor: 5.182

6.  Adrenaline reveals the torsadogenic effect of combined blockade of potassium channels in anaesthetized guinea pigs.

Authors:  G Michael; K A Kane; S J Coker
Journal:  Br J Pharmacol       Date:  2008-05-19       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.